SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Drug Development
Merck & Co., Inc.'s Vioxx Heart Risk Persists One Year After Stopping Use, University of Texas MD Anderson Cancer Center Study
October 14, 2008
 · 
1 min read
Drug Development
Chemo Alone Effective in Treating Kids’ Brain Tumors, University of Texas MD Anderson Cancer Center Study
October 13, 2008
 · 
1 min read
Lone Star Bio
Artificial Heart Technology Holds Promise For Alternatives, Texas Heart Institute And University of Houston Report
October 10, 2008
 · 
1 min read
Lone Star Bio
RNA Molecules, Delivery System Improve Vaccine Responses, Effectiveness, University of Texas Study
October 9, 2008
 · 
1 min read
Policy
Federal Preemption Part 2: Medical Devices As A Case Study
October 8, 2008
 · 
1 min read
Lone Star Bio
Tamoxifen Chemoprevention Tied To Early Detection Of Breast Cancer, University of Texas MD Anderson Cancer Center Study
October 8, 2008
 · 
1 min read
Lone Star Bio
Robotic Surgery Lowers Risk Of A Rare But Serious Complication Of Gastric Bypass, University of Texas Medical School Study Suggests
September 30, 2008
 · 
1 min read
Lone Star Bio
Deactivating A Cancer Growth Promoter, Baylor College of Medicine Study
September 29, 2008
 · 
1 min read
Lone Star Bio
Enzyme Blocks Bug-Induced Secondary Illnesses, University of Texas Southwestern Medical Center Study
September 29, 2008
 · 
1 min read
Lone Star Bio
Studies Ignite Hope for Long-Acting Allergy Vaccines; New Ragweed Regimens Would Be More Convenient And Effective, Lovelace Scientific Resources Researchers Say
September 29, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Press Releases
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
January 13, 2026
 · 
10 min read
Load More